Conversely, a high number of CD206+ TAMs and an increase in the CD206/CD68 ratio are correlated with decreased DFS and OS rates after fluorouracil-based chemotherapy in stage II colon cancer patients [36]. The gene discussed is MRC1; the disease is colonic neoplasm.